Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.012x

Based on the latest financial reports, Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a cash flow conversion efficiency ratio of 0.012x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥110.78 Million ≈ $16.21 Million USD) by net assets (CN¥9.02 Billion ≈ $1.32 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Tianjin Zhongxin Pharmaceutical Group Co balance sheet independence to measure how much of total assets are equity-financed.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd - Cash Flow Conversion Efficiency Trend (2001–2024)

This chart illustrates how Tianjin Zhongxin Pharmaceutical Group Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Tianjin Zhongxin Pharmaceutical Group Co to evaluate the quality of earnings relative to operating cash generation.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tianjin Zhongxin Pharmaceutical Group Corp Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Henan Mingtai Al.Industrial Co Ltd SHG:601677	-0.013x
Sigma Advanced Systems Limited NSE:MEGASOFT	-0.777x
Green Brick Partners Inc NYSE:GRBK	0.028x
China Wafer Level Csp Co Ltd SHG:603005	0.031x
Sichuan Yahua Industrial Group Co Ltd SHE:002497	0.001x
Beijing Capital Co Ltd SHG:600008	0.023x
Bucher Industries AG SW:BUCN	0.183x
FangDa Carbon New Material Co Ltd SHG:600516	-0.012x

Annual Cash Flow Conversion Efficiency for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)

The table below shows the annual cash flow conversion efficiency of Tianjin Zhongxin Pharmaceutical Group Corp Ltd from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see Tianjin Zhongxin Pharmaceutical Group Co stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥7.85 Billion ≈ $1.15 Billion	CN¥924.67 Million ≈ $135.31 Million	0.118x	+13.69%
2023-12-31	CN¥6.65 Billion ≈ $972.41 Million	CN¥688.49 Million ≈ $100.75 Million	0.104x	+0.23%
2022-12-31	CN¥6.55 Billion ≈ $958.76 Million	CN¥677.25 Million ≈ $99.10 Million	0.103x	-21.01%
2021-12-31	CN¥6.51 Billion ≈ $953.18 Million	CN¥852.40 Million ≈ $124.73 Million	0.131x	+15.96%
2020-12-31	CN¥5.95 Billion ≈ $870.66 Million	CN¥671.42 Million ≈ $98.25 Million	0.113x	+25.79%
2019-12-31	CN¥5.52 Billion ≈ $808.22 Million	CN¥495.49 Million ≈ $72.51 Million	0.090x	+29.50%
2018-12-31	CN¥5.05 Billion ≈ $739.62 Million	CN¥350.14 Million ≈ $51.24 Million	0.069x	+8165.98%
2017-12-31	CN¥4.63 Billion ≈ $676.85 Million	CN¥-3.97 Million ≈ $-581.32K	-0.001x	-100.88%
2016-12-31	CN¥4.30 Billion ≈ $629.56 Million	CN¥419.90 Million ≈ $61.44 Million	0.098x	+11.12%
2015-12-31	CN¥4.11 Billion ≈ $600.72 Million	CN¥360.58 Million ≈ $52.76 Million	0.088x	-9.77%
2014-12-31	CN¥2.95 Billion ≈ $431.19 Million	CN¥286.85 Million ≈ $41.98 Million	0.097x	+17.45%
2013-12-31	CN¥2.57 Billion ≈ $376.80 Million	CN¥213.44 Million ≈ $31.23 Million	0.083x	+807.71%
2012-12-31	CN¥2.28 Billion ≈ $333.46 Million	CN¥20.81 Million ≈ $3.04 Million	0.009x	-88.42%
2011-12-31	CN¥2.21 Billion ≈ $322.67 Million	CN¥173.88 Million ≈ $25.44 Million	0.079x	+18.36%
2010-12-31	CN¥2.09 Billion ≈ $305.38 Million	CN¥139.04 Million ≈ $20.35 Million	0.067x	+42.83%
2009-12-31	CN¥1.79 Billion ≈ $261.66 Million	CN¥83.41 Million ≈ $12.21 Million	0.047x	-55.90%
2008-12-31	CN¥1.47 Billion ≈ $215.50 Million	CN¥155.77 Million ≈ $22.79 Million	0.106x	+606.94%
2007-12-31	CN¥1.35 Billion ≈ $196.89 Million	CN¥20.13 Million ≈ $2.95 Million	0.015x	+175.03%
2006-12-31	CN¥1.41 Billion ≈ $206.07 Million	CN¥-28.08 Million ≈ $-4.11 Million	-0.020x	-114.84%
2005-12-31	CN¥1.95 Billion ≈ $285.17 Million	CN¥261.91 Million ≈ $38.33 Million	0.134x	+2304.03%
2004-12-31	CN¥1.88 Billion ≈ $274.74 Million	CN¥10.50 Million ≈ $1.54 Million	0.006x	-86.57%
2003-12-31	CN¥1.84 Billion ≈ $269.08 Million	CN¥76.57 Million ≈ $11.20 Million	0.042x	-62.51%
2002-12-31	CN¥1.69 Billion ≈ $247.19 Million	CN¥187.60 Million ≈ $27.45 Million	0.111x	+8.52%
2001-12-31	CN¥1.54 Billion ≈ $225.52 Million	CN¥157.73 Million ≈ $23.08 Million	0.102x	--

About Tianjin Zhongxin Pharmaceutical Group Corp Ltd

SHG:600329 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.08 Billion

CN¥21.02 Billion CNY

Market Cap Rank

#4827 Global

#811 in China

Share Price

CN¥36.87

Change (1 day)

-1.15%

52-Week Range

CN¥35.50 - CN¥50.05

All Time High

CN¥54.12